Navodi Jayathilaka: The First CRISPR-Edited Babies – A Moment That Changed History
Navodi Jayathilaka, Lecturer and Academic Coordinator at International Institute of Health Sciences, shared a post on LinkedIn:
“The First CRISPR-Edited Babies: A Moment That Changed History
Lulu and Nana made headlines as the first babies born with CRISPR-edited genomes. The experiment, led by Chinese scientist He Jiankui, sought to modify their CCR5 gene, providing resistance to HIV.
But this groundbreaking achievement didn’t come without controversy.
- Ethical debates erupted worldwide, questioning the implications of gene editing in human embryos.
- Was this a leap toward medical progress, or did it cross a line we’re not ready to explore?
Fast forward to today, and the conversation is still going strong. The potential of CRISPR is undeniable, but so are the risks. As the science advances, the question remains – How far should we go in altering the human genome?
What are your thoughts on the ethical boundaries of genetic engineering?”
Read the full article.
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Dec 21, 2025, 02:55Epigenetic Links Between Paternal Age, Reproduction and Offspring Health – Reproduction and Fertility
-
Dec 21, 2025, 02:43Medicines and Pregnancy: ANSM Proposes New Labeling – B’RIGHT
-
Dec 21, 2025, 02:28Steven Palter: It is time to retire the out of date ‘2 week wait’ for pregnancy tests after IVF
-
Dec 21, 2025, 02:24Thorsten Waloschek: New Study Highlights Preeclampsia Risk Stratification Benefits
-
Dec 21, 2025, 02:15Siddhartha Yadav: New ASCO Guideline for Managing Cancer During Pregnancy
-
Dec 21, 2025, 01:56New Patient Resource on Thyroid Issues in Pregnancy – RCOG
-
Dec 21, 2025, 01:49CDC Releases 2024 Pregnancy Mortality Data – Preeclampsia Foundation
-
Dec 21, 2025, 01:30Caitlin Wyrwoll: New Insights on Maternal Health and Extreme Heat
-
Dec 20, 2025, 10:57Clare Pin-Chia Huang: New Research Links Maternal Diabetes to Pregnancy Risks